Manufacturing proficiency has been Arion Group's forte ever since its inception. State-of-the-art facilities with latest advanced manufacturing techniques help the organization cater to global demand with high-quality and affordable medicines.
The company has R&D Centres, two pilot plants, and two process safety screening labs. All facilities are cGMP compliant and approved by major international regulatory agencies.
We are consistently developing a formulation portfolio and pipeline across our formulation facilities:
We continue to build our future pipeline of complex products with our established robust portfolio selection process, providing early launch capabilities along with Intellectual Property (IP) advantages. Selective vertical integration, scale and more importantly its investments in manufacturing and quality have helped the company build a quality product pipeline.